反応 #316575

ord-d0499e2b55a54ff682b2991967d7545d

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他The product was purified via Biotage Horizon® (25S, silica, gradient from 5% EtOAc/hexane to 40% EtOAc/hexane)
  2. 2
    その他isolated as a white foam

実験手順

7-Bromo-4-tert-butyl-5-(2,4-dimethoxybenzoyl)-4,5-dihydropyrrolo[1,2-a]quinoxaline was prepared from 7-bromo-4-tert-butyl-4,5-dihydropyrrolo[1,2-a]quinoxaline (see Example 114, Step 1) and 2,4-dimethoxybenzoyl chloride according to the procedure of Example 106, Step 2. The product was purified via Biotage Horizon® (25S, silica, gradient from 5% EtOAc/hexane to 40% EtOAc/hexane) and isolated as a white foam. MS (ESI) m/z 469/471 ([M+H]+); HRMS: calcd for C24H25BrN2O3, 468.1049; found (ESI+), 469.11175.

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07563793B2uspto-grants-2009_07